Jon Garinn

Researchers are looking for genetic variations to determine which patients have an increased risk for a second cancer and should receive different treatments.

Patients with myelofibrosis have few options for relief from an enlarged spleen, a side effect of the cancer, but there is hope on the horizon.

Researchers urge restraint when it comes to treating thyroid cancer in children.

Biomarker research might reveal neuropathy risk with certain cancer therapies.

HPV-positive oral cancers are on the rise.

New cancer cell-trapping method could result in improved treatment.